Schwab I, Nimmerjahn F (2013)
Publication Status: Published
Publication Type: Journal article, Review article
Publication year: 2013
Book Volume: 13
Pages Range: 176-89
Journal Issue: 3
DOI: 10.1038/nri3401
Intravenous immunoglobulin (IVIG) preparations comprise pooled IgG antibodies from the serum of thousands of donors and were initially used as an IgG replacement therapy in immunocompromised patients. Since the discovery, more than 30 years ago, that IVIG therapy can ameliorate immune thrombocytopenia, the use of IVIG preparations has been extended to a wide range of autoimmune and inflammatory diseases. Despite the broad efficacy of IVIG therapy, its modes of action remain unclear. In this Review, we cover the recent insights into the molecular and cellular pathways that are involved in IVIG-mediated immunosuppression, with a particular focus on IVIG as a therapy for IgG-dependent autoimmune diseases.
APA:
Schwab, I., & Nimmerjahn, F. (2013). Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nature reviews. Immunology, 13(3), 176-89. https://dx.doi.org/10.1038/nri3401
MLA:
Schwab, Inessa, and Falk Nimmerjahn. "Intravenous immunoglobulin therapy: how does IgG modulate the immune system?" Nature reviews. Immunology 13.3 (2013): 176-89.
BibTeX: Download